Viomycin, 1-[(3R,4R)-4-hydroxy-3,6-diaminohexanoicacid]-6-[L-2-(2-amino-1,4,5,6-tetrahydro-4-pyrimidinyl)glycine]-, (R)-;1,4,7,10,13-Pentaazacyclohexadecane, cyclic peptide deriv.;Cyclo[(2Z)-3-[(aminocarbonyl)amino]-2,3-didehydroalanyl-(2S)-2-[(4R)-2-amino-3,4,5,6-tetrahydro-4-pyrimidinyl]glycyl-(2S)-2-[[(3R,4R)-3,6-diamino-4-hydroxy-1-oxohexyl]amino]-b-alanyl-L-seryl-L-seryl];TuberactinomycinN (8CI,9CI); Enviomycin; 

Celiomycin; AC1MI3VU; 32988-50-4; Tuberactinomycin B;(3S)-3,6-diamino-N-[(3S,6Z,9S,12S,15S)-3-[(4S,6R)-2-amino-4-hydroxy-1,4,
5,6-tetrahydropyrimidin-6-yl]-6-[(carbamoylamino)methylidene]-9,
12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,
13-pentazacyclohexadec-15-yl]hexanamide; Viomycine; Viomicina; Florimycin; Viomycin (VM); Viomycinum; 

Tuberactinamine-N;AC1MI3A2;(R)-1-de(L-3,6-Diaminohexanoic acid)-6-(L-2-(2-amino-1,4,5,6-tetrahydro-4-pyrimidinyl)glycine) viomycin;[(Z)-[(3S,9S,12S,15S)-15-amino-3-[(6R)-2-amino-1,4,5,6-tetrahydropyrimidin-6-yl]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-6-ylidene]methyl]urea;56257-31-9 

TuberactinomycinO (8CI,9CI);1,4,7,10,13-Pentaazacyclohexadecane, cyclic peptide deriv.;13)-lactam, (2S)-; Viomycin,6-[L-2-(2-amino-1,4,5,6-tetrahydro-4-pyrimidinyl)glycine]-, (R)-;Glycine,3-amino-N-[(3S)-3,6-diamino-1-oxohexyl]-L-alanyl-L-seryl-L-seryl-(2Z)-3-[(aminocarbonyl)amino]-2,3-didehydroalanyl-2-[(4R)-2-amino-3,4,5,6-tetrahydro-4-pyrimidinyl]-,(5® 

Viomycin, tris(3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate) (salt); 

VIOMYCIN SULFATE;viomycin sulphate;viomycin-sulfat;solfatodiviomicina;florimycinsulfate;viomycin,sulfate(salt);celicomycin-sulfate;Viomycin sulfate (JAN);viocinsulfate; 

Broxoviomycin;Viomycin,5-(2-hydroxyglycine)- (9CI);1,4,7,10,13-Pentaazacyclohexadecane,cyclic peptide deriv.;